Patent · US Expired

6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

US4906624A · kind A · utility

27Cited by
5References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 1988
Grant dateMar 6, 1990
Priority date
Expiry dateAug 2, 2008

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Certain trans-6-[[(substituted)pyridin-3-yl]-alkyl- and alkenyl]tetrahydro-4-hydroxypyran-2-ones and the corresponding ring-opened acids derived therefrom are potent inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) and are useful as hypocholesterolemic and hypolipidemic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.